Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Oct;90(4):911-40.
doi: 10.1016/j.fertnstert.2008.08.067.

Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing

D Andrew Crain  1 , Sarah J Janssen, Thea M Edwards, Jerrold Heindel, Shuk-mei Ho, Patricia Hunt, Taisen Iguchi, Anders Juul, John A McLachlan, Jackie Schwartz, Niels Skakkebaek, Ana M Soto, Shanna Swan, Cheryl Walker, Teresa K Woodruff, Tracey J Woodruff, Linda C Giudice, Louis J Guillette Jr
Affiliations
Review

Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing

D Andrew Crain et al. Fertil Steril. 2008 Oct.

Abstract

Objective: To evaluate the possible role of endocrine-disrupting compounds (EDCs) on female reproductive disorders emphasizing developmental plasticity and the complexity of endocrine-dependent ontogeny of reproductive organs. Declining conception rates and the high incidence of female reproductive disruptions warrant evaluation of the impact of EDCs on female reproductive health.

Design: Publications related to the contribution of EDCs to disorders of the ovary (aneuploidy, polycystic ovary syndrome, and altered cyclicity), uterus (endometriosis, uterine fibroids, fetal growth restriction, and pregnancy loss), breast (breast cancer, reduced duration of lactation), and pubertal timing were identified, reviewed, and summarized at a workshop.

Conclusion(s): The data reviewed illustrate that EDCs contribute to numerous human female reproductive disorders and emphasize the sensitivity of early life-stage exposures. Many research gaps are identified that limit full understanding of the contribution of EDCs to female reproductive problems. Moreover, there is an urgent need to reduce the incidence of these reproductive disorders, which can be addressed by correlative studies on early life exposure and adult reproductive dysfunction together with tools to assess the specific exposures and methods to block their effects. This review of the EDC literature as it relates to female health provides an important platform on which women's health can be improved.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Development of the PCOS phenotype. The combined influence of genetically inherited factors and embryonic and fetal exposure to environmental factors leads to the onset of PCOS in adulthood. The metabolic, as well as reproductive, disruptions associated with PCOS phenotype are shown. Based on Xita and Tsatsoulis (53).
FIGURE 2
FIGURE 2
Environmental factors influencing early puberty.
FIGURE 3
FIGURE 3
Well-defined developmental periods of sensitivity when EDC exposure greatly increases the risk for reproductive disorders.
See this image and copyright information in PMC

References

    1. Foster WG, Neal MS, Han MS, Dominguez MM. Environmental contaminants and human infertility: hypothesis or cause for concern? J Toxicol Environ Health B Crit Rev. 2008;11:162–76. - PubMed
    1. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette LJ, Jr, et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect. 1996;104(Suppl 4):741–803. - PMC - PubMed
    1. Caserta D, Maranghi L, Mantovani A, Marci R, Maranghi F, Moscarini M. Impact of endocrine disruptor chemicals in gynaecology. Hum Reprod Update. 2008;14:59–72. - PubMed
    1. Genuis SJ. Health issues and the environment-an emerging paradigm for providers of obstetrical and gynaecological health care. Hum Reprod. 2006;21:2201–8. - PubMed
    1. Giudice LC. Infertility and the environment: the medical context. Semin Reprod Med. 2006;24:129–33. - PubMed

Substances